Latest From Biotech Now

Industry Comes Together to Improve the Introduction of Ag Biotech Products into the Marketplace

GMO soybeans

Representatives of several farm, grain trade and biotech companies have been meeting on a regular basis to try to develop better “rules of the road” for the introduction of new ag biotech products. Agripulse covered the story on how the U.S. Biotech Crops Alliance (USBCA) is working to find common ground on the introduction, stewardship, and distribution of commodities and processed products containing or derived from modern biotechnology. The USBCA’s founding organizations are the National Corn Growers Association, Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , ,

New PhRMA Report: A Decade of Innovation in Rare Diseases


Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in Rare Diseases,” which highlights 10 years of progress in understanding rare diseases and drug development resulting in groundbreaking therapies. According to the report, more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development. The Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The Administration Focuses on Improving Food Safety


The Obama administration wants to establish a new agency that would be housed within the Department of Health and Human Services and serve as the primary voice on food safety standards and compliance with those standards. The Agency would be named the Food Safety Administration, the Obama administration said in its new budget request. The New York Times covered the story here: …At least 15 government agencies — from the Environmental Protection Agency to the National Oceanic and Atmospheric Administration — have Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO IPCC Spring Conference Program Announced


BIO’s 2015 IP Counsels Committee Spring Conference & Meeting will be held April 15-17 in St. Louis, Missouri, at the Four Seasons St. Louis Hotel. The biannual conference offers timely, relevant educational sessions on the latest issues in the biotech IP sector, informal networking events designed to promote discussion and foster relationships among industry colleagues, and practical tips for attendees to use the next day. Attendees will hear from the foremost experts in biotech IP Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

Getting Ready for #RDD2015 (Rare Disease Day 2015)


Rare Disease Day is just around the corner on February 28th. R&D investment into rare disease research by venture capitalists was a major focus of BIO’s recent Venture Funding of Therapeutic Innovation between 2004-2013, available for download here. One of the more interesting findings in the study is the large increase of funding by venture capitalists for rare disease R&D over the past decade, as this chart illustrates: Over the last 10 years, there has Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,